In today’s Pharma/Biotech industry, the growing complexity and diversity of therapeutic product lines, as well as the acceleration of clinical trial processes, has put your Chemistry, Manufacturing and Controls (CMC) organization on the critical path for commercial product launches. Speeding innovative and successful new drugs to patients will require the end-to-end, digital transformation of CMC processes. 

This talk explores Dassault Systèmes’ digital laboratory solution with an emphasis on cross-domain integration and real-time, consistent, synchronized and standardized information flow from R&D to manufacturing. Learn how your CMC teams can automate document creation and laboratory processes and document creation to simplify and speed workflows. See how “always-on,” digital lab informatics services (SaaS on the cloud) can improve collaborative innovation and productivity across your global CMC organization.

Watch this webcast to:

• Learn how automated lab processes secure IP, streamline data acquisition, and increase compliance
• See how S88-based procedures standardize data and accelerate tech transfer
• Learn how customers are leveraging fully digitalized CMC processes with BIOVIA

Speaker:

Dennis Curran

Portfolio Director

BIOVIA, Dassault Systèmes

Dennis Curran is the lead of the laboratory software portfolio for BIOVIA Dassault Systèmes with a focus on the integration of BIOVIA products into customer solutions for scientific research and development. Areas of primary responsibility include BIOVIA Laboratory Solutions and mapping the product transition to the 3DEXPERIENCE platform. His direct pharmaceutical experience includes running the robotics laboratories for Parke-Davis’s Analytical Development department in New Jersey.